Email Updates

You are here

Home

27 MARCH 2020 VOLUME 22 ISSUE 12

Media Coverage

  • Breaking: US, Mexico AIDS Confabs to Go Virtual

    Organizers of the 2020 International AIDS Conference announced Friday that the in-person meeting, scheduled for July 7-10 in San Francisco and Oakland, will be replaced with a virtual conference in the wake of the ongoing coronavirus crisis. Planners of HIV2020, a parallel community-based conference slated for Mexico City at the same time, reached a similar decision.

    March 27, 2020
    General
    Bay Area Reporter

  • COVID-19 Needs a Manhattan Project

    There is an unprecedented race to develop a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With at least 44 vaccines in early-stage development, what outcome can we expect? Will the first vaccine to cross the finish line be the safest and most effective? Or will it be the most well-funded vaccines that first become available, or perhaps those using vaccine technologies with the fewest regulatory hurdles? The answer could be a vaccine that ticks all these boxes.

    March 27, 2020
    General
    Science

  • HIV PrEP Also Prevents Hepatitis B – And Works Better Than the Hepatitis B Vaccine

    A retrospective cohort study of gay and bisexual men attending sexual health clinics in Japan shows that taking HIV pre-exposure prophylaxis (PrEP) not only protects against HIV but also against infection with hepatitis B, reducing the risk of it nearly tenfold. The study was presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2020).

    March 26, 2020
    PrEP
    aidsmap

  • How Monoclonal Antibodies Might Prove Useful Against The Coronavirus

    When our bodies are invaded by a virus, our immune systems make particular proteins called antibodies to help fight off infection. Scientists working to quell the COVID-19 pandemic think it will be possible to figure out which antibodies are most potent in quashing a coronavirus infection, and then make vast quantities of identical copies of these proteins synthetically.

    March 26, 2020
    Antibody Related Research
    NPR

  • Can Deborah Birx Save Us?

    After years of looming large in the relatively insular world of international AIDS work, Birx is now on the global stage in an unprecedented way — joining the White House for its daily briefings, urging millennials to take precautions, explaining what she has figured out about different ventilator masks. Each time she takes the stage alongside President Trump, she’s alternately pilloried and praised on social media for hanging tough through his freewheeling, fact-flouting remarks.

    March 26, 2020
    Washington Post

  • Deborah Birx, AIDS Researcher, Takes a Prominent Role in Coronavirus Messaging for Trump Administration

    When the urgent phone call came last month, respected HIV researcher Deborah Birx was meeting with African officials and activists from around the world at a Johannesburg conference to help determine how US AIDS relief funding would be doled out.

    March 25, 2020
    General
    Los Angeles Times

  • What the Female Reproductive Tract Could Tell Kenyan Researchers About HIV

    In Kenya, researchers are trying to better understand this transmission route into the female body. Scientists at KAVI Institute of Clinical Research, at the University of Nairobi, are examining how the virus interacts with the mucus lining in the female reproductive tract, with an ultimate aim to find a technique that stops HIV at one of its entry points. This is the first research of its kind in sub-Saharan Africa.

    March 25, 2020
    General
    Devex

  • HIV Cure at CROI: New Data on Antibodies, Vaccines and Genetically Engineered T-Cells

    Two different approaches towards achieving a cure for HIV produced tantalising new data at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2020). This annual conference was due to take place in Boston from 8 to 11 March but in-person attendance was cancelled two days before the conference was due to open and was replaced by online presentations. Even more impressively, the Community Cure Workshop, which has been held the day before CROI for several years, was cancelled at one day’s notice but still happened via live streaming.

    March 24, 2020
    Antibody Related Research, HIV Vaccine, Cure
    aidsmap

  • Canada Is the First to Approve Long-Acting HIV Regimen Cabenuva

    HIV treatment has entered an exciting new era as Canada has become the first nation in the world to approve ViiV Healthcare’s monthly long-acting injectable antiretroviral (ARV) regimen Cabenuva (cabotegravir/rilpivirine)—the first complete regimen for treating the virus that does not require daily pills.

    March 23, 2020
    Treatment
    POZ

  • African HIV Responders’ Funding Hit Hardest by US Abortion “Gag Rule”

    Organizations working to end the HIV/AIDS epidemic in Africa have been the most impacted by President Donald Trump’s 2017 revival of the “gag rule,” which prohibits overseas public health grants to entities that offer abortion services, referrals or advocacy. HIV/AIDS organizations are losing millions of dollars in funding—even more than those dedicated specifically to reproductive health.

    March 23, 2020
    General
    Filter

  • What We’ve Learned From the HIV Pandemic

    As people who have worked to respond to the HIV pandemic for most of our adult lives — one of us as an HIV activist and the other as an epidemiologist — we understand the consequences of early mistakes in the response to disease outbreaks and how politicians can often stand in the way of protecting the public's health.

    March 21, 2020
    General
    CNN

Published Research

Announcements